Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts
=====================================================================================================================================================================

* Rachel A Woolaver
* Xiaoguang Wang
* Alexandra L Krinsky
* Brittany C Waschke
* Samantha M Y Chen
* Vince Popolizio
* Andrew G Nicklawsky
* Dexiang Gao
* Zhangguo Chen
* Antonio Jimeno
* Xiao-Jing Wang
* Jing Hong Wang